• Product NameFavipiravir (T-705)
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityFavipiravir (T-705) is a potent and selective RNA-dependent RNA polymerase inhibitor, used to treat influenza virus infections.
• Target NameOthers inhibitor
• CAS No. 259793-96-9
• Calculated MW 157.1
• Formulation C5H4FN3O2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Others
  SMILES:NC(=O)C1=NC(F)=CN=C1O |c:6,8,t:3|
  Pathways:Others
  Receptor:RNA-dependent RNA polymerase
  Boling pt:
  Melting pt:
  Solubility:Ethanol: 22 mg/mL warmed (140.03 mM) DMSO: 31 mg/mL (197.32 mM) Water: 5 mg/mL warmed (31.82 mM)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1.Favipiravir: RNA-directed RNA polymerase NS5B inhibitor treatment of influenza A By Reviriego, C.From Drugs of the Future (2010), 35(9), 713-717.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting